REFERENCES
- Bando S, Mohri F, Yamashita Y, Takakura F, Hashida M. Effect of skin metabolism on percutaneous absorption of lipophilic drugs. J. Pharm. Sci. 1997; 86: 759–761
- Mukai E, Arase K, Hashida M, Sezaki H. Enhanced delivery of mitomicin C prodrugs through the skin. Int. J. Pharm 1985; 25: 95–103
- Chan SY, Po LW. Prodrug for dermal delivery. Int. J. Pharm. 1987; 55: 1–16
- Itoh T, Xia J, Magavi R, Nishihata T, Rytting JH. Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: comparison with human skin. Pharm. Res. 1990; 7: 1042–1047
- Hirvonen JH, Rytting JH, Paronen P, Urtti A. Dodecyl N, N-dimethylamino acetate and azone enhance drug permeation across human, snake and rabbit skin. Pharm. Res. 1991; 8: 933–937
- Harada K, Murakami T, Kawasaki E, Higashi Y, Yamamoto S, Yata N. In vitro permeability to salicylic acid of human, rodent, and shed snake skin. J. Pharm. Pharmacol. 1993; 45: 414–418
- Pongjanyakul T, Prakongpan S, Priprem A. Permeation studies comparing cobra skin with human skin using nicotine transdermal patches. Drug. Dev. Ind. Pharm. 2000; 26: 635–642
- Pongjanyakul T, Prakongpan S, Panomsuk S, Puttipipatkhachorn S, Priprem A. Shed king cobra and cobra skins as model membrane for in vitro nicotine permeation studies. J. Pharm. Pharmacol. 2002; 54: 1345–1350
- Haigh JM, Beyssac E, Chanet L, Aiache JM. In vitro permeation of progesterone from gel through the shed snake skin of three different snake species. Int. J. Pharm. 1998; 170: 151–156
- Nghiem BT, Higuchi T. Esterase activity in shed snake skin. Int. J. Pharm. 1988; 44: 125–130
- Ngawhirunpat T, Panomsuk S, Opanasopit P, Rojanarata T, Hatanaka T. Comparison of the percutaneous absorption of hydrophilic and lipophilic compounds in shed snake skin and human skin. Pharmazie. 2006; 61: 331–335
- OECD. Skin absorption: In vitro method. OECD New Guideline Proposal on In Vitro Percutaneous Absorption of Chemicals. OECD, Paris 2001, Test Guideline 428.
- Burger S, Murray S, Gaines KF, Novak JF, Punshon T, Dixon C. Element levels in snakes in South Carolina: differences between a control site and exposed site on the Savannah River Site. Environ. Monit. Assess. 2006; 112: 35–52
- Opanasopit P, Panomsuk S, Ngawhirunpat T, Meeim K, Suratannont J, Tannikkul C. Development and evaluation of polymeric matices for isosorbide dinitrate transdermal drug delivery systems. Thai. J. Pharm. Sci. 2001; 22: 125–136
- Hatanaka T, Inuma M, Sugibayashi K, Morimoto Y. Prediction of skin permeability of drugs I: Comparison with artificial membrane. Chem. Pharm. Bull. 1990; 38: 3452–3459
- Bronaugh RL, Stewart RF, Simon M. Methods for in vitro percutaneous absorption studies. VII. Use of excised human skin. J. Pharm. Sci. 1986; 75: 1094–1097
- Bronaugh RL, Stewart RF, Storm JE. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. Toxicol. Appl. Pharmacol. 1989; 99: 534–543
- Knutson K, Potts RO, Guzek DB, Golden GM, Mckie JE, Lambert WJ, Higuchi WI. Macro and molecular physical-chemical consideration in understanding drug transport in stratum corneum. J. Control. Rel. 1985; 2: 67–87
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
- Rittirod T, Hatanaka T, Uraki A, Hino K, Katayama K, Koizumi T. Species difference in skin transport and metabolism of ethyl nicotinate in skin. Int. J. Pharm 1999; 178: 161–169
- Ngawhirunpat T, Hatanaka T, Kawakami J, Adachi I. Age difference in simultaneous permeation and metabolism of ethyl nicotinate in rat skin. Biol. Pharm. Bull. 2001; 24: 414–417
- Takahashi K, Tamagawa S, Katagi T, Rytting H, Nishihata T, Mizuno N. Percutaneous absorption of basic compounds through shed snake skin as model membrane. J. Pharm. Pharmacol. 1993; 45: 882–886
- Sato K, Sugibayashi K, Morimoto Y. Species differences in percutaneous absorption of nicorandil. J. Pharm. Sci. 1991; 80: 104–107
- Dick IP, Scott RC. The influence of different strains and age on in vitro rat skin permeation to water and mannitol. Pharm. Res. 1992; 9: 884–887
- Martin RJ, Denyer P, Hadgraft J. Skin metabolism of topically applied compound. Int. J. Pharm. 1987; 39: 23–32
- Tojo K, Yamada K, Hikima T. Diffusion and metabolism of prednisolone fanesylate in viable skin of the hairless mouse. Pharm. Res. 1994; 11: 393–397
- Sugibayashi K, Hayashi T, Hatanaka T, Ogihara M, Morimoto Y. Analysis of simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin. Pharm. Res. 1996; 13: 855–860